This research clinical trial is studying the creation and administration of GVAX, an
irradiated GM-CSF secreting, autologous neuroblastoma cell vaccine (GVAX) in combination with
nivolumab and ipilimumab as a possible treatment for neuroblastoma.
The names of the study drugs involved in this study are:
- GVAX Vaccine, an immunotherapy developed from surgically removed tumor tissue
- Nivolumab
- Ipilimumab